Duloxetine Metabolism and Fibromyalgia

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

People with fibromyalgia report generalized body pain (pain all over), increased sensitivity to painful stimulation, chronic tiredness or low energy, sleep problems, and other physical and functional problems. The exact cause of the disorder is poorly understood, and treatment can be difficult. The degree to which duloxetine is helpful for people with fibromyalgia varies greatly. For some people, it is very helpful for managing fibromyalgia symptoms. For others, people may not notice any benefit. Yet for some, it is a little helpful and the effect is noticeable only when people forget to take the medicine. The purpose of this study is to collect data to better understand the relationship among gene types that control those enzymes, blood concentrations of duloxetine, and how it helps the symptoms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults 18+

• Meeting diagnostic criteria for Fibromyalgia

• Patients taking Duloxetine 60 mg/day for at least 8 weeks

Locations
United States
Utah
Pain Management Center and Pain Research Center at the University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Jake Steenblick, DNP
jacob.steenblik@nurs.utah.edu
801-585-1216
Backup
Natalie R Bennion, MPH
Natalie.Bennion@utah.edu
801-585-7697
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 100
Treatments
Adult patients treated with duloxetine for fibromyalgia
Adults 18+~Meeting diagnostic criteria for Fibromyalgia~Patients taking Duloxetine 60 mg/day for at least 8 weeks
Related Therapeutic Areas
Sponsors
Leads: University of Utah

This content was sourced from clinicaltrials.gov